Guy Hechmati

916 total citations
51 papers, 666 citations indexed

About

Guy Hechmati is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guy Hechmati has authored 51 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 23 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guy Hechmati's work include Bone health and treatments (36 papers), Cancer Diagnosis and Treatment (21 papers) and Management of metastatic bone disease (20 papers). Guy Hechmati is often cited by papers focused on Bone health and treatments (36 papers), Cancer Diagnosis and Treatment (21 papers) and Management of metastatic bone disease (20 papers). Guy Hechmati collaborates with scholars based in Switzerland, United States and United Kingdom. Guy Hechmati's co-authors include Francesca Gatta, Jean‐Jacques Body, Yi Qian, Marc Peeters, Roger von Moos, Jan-Henrik Terwey, George Kafatos, Aliki Taylor, J. Han van Krieken and Kelly S. Oliner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Guy Hechmati

51 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Hechmati Switzerland 17 532 202 186 119 94 51 666
Stephen S. Grubbs United States 10 354 0.7× 110 0.5× 78 0.4× 108 0.9× 40 0.4× 30 538
Lucy McParland United Kingdom 13 304 0.6× 228 1.1× 151 0.8× 46 0.4× 85 0.9× 28 999
Mario R. Velasco United States 13 406 0.8× 162 0.8× 124 0.7× 72 0.6× 41 0.4× 23 646
Robert R. Carroll United States 10 705 1.3× 184 0.9× 126 0.7× 100 0.8× 33 0.4× 14 894
Candice Johnstone United States 11 295 0.6× 334 1.7× 160 0.9× 121 1.0× 34 0.4× 44 660
Dirk Elling Germany 16 303 0.6× 115 0.6× 194 1.0× 40 0.3× 65 0.7× 51 656
Karin Olson United States 15 262 0.5× 384 1.9× 79 0.4× 73 0.6× 10 0.1× 34 620
Sophie Tartas France 12 248 0.5× 141 0.7× 35 0.2× 232 1.9× 148 1.6× 33 720
Amit Bahl India 10 186 0.3× 133 0.7× 143 0.8× 68 0.6× 22 0.2× 46 367
Şefik İğdem Türkiye 16 178 0.3× 148 0.7× 193 1.0× 88 0.7× 140 1.5× 36 608

Countries citing papers authored by Guy Hechmati

Since Specialization
Citations

This map shows the geographic impact of Guy Hechmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Hechmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Hechmati more than expected).

Fields of papers citing papers by Guy Hechmati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Hechmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Hechmati. The network helps show where Guy Hechmati may publish in the future.

Co-authorship network of co-authors of Guy Hechmati

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Hechmati. A scholar is included among the top collaborators of Guy Hechmati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Hechmati. Guy Hechmati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Yi, Jorge Arellano, Francesca Gatta, et al.. (2018). Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom. BMC Health Services Research. 18(1). 518–518. 6 indexed citations
2.
Moos, Roger von, Jean-Jacques Body, Evangelos Terpos, et al.. (2018). Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. Journal of bone oncology. 10. 49–56. 3 indexed citations
3.
Body, Jean-Jacques, Francesca Gatta, E De Cock, et al.. (2017). An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. Supportive Care in Cancer. 25(9). 2823–2832. 9 indexed citations
4.
Pereira, João, Jean‐Jacques Body, Oliver Günther, et al.. (2016). Cost of skeletal complications from bone metastases in six European countries. Journal of Medical Economics. 19(6). 611–618. 22 indexed citations
5.
Koukakis, Reija, Francesca Gatta, Guy Hechmati, & Salvatore Siena. (2016). Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials. Quality of Life Research. 25(10). 2645–2656. 13 indexed citations
6.
Graham, Christopher N., Gregory A. Maglinte, Lee S. Schwartzberg, et al.. (2016). Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy. Clinical Therapeutics. 38(6). 1376–1391. 9 indexed citations
7.
Arellano, Jorge, Brett Hauber, Ateesha F. Mohamed, et al.. (2015). Physicians’ Preferences for Bone Metastases Drug Therapy in the United States. Value in Health. 18(1). 78–83. 22 indexed citations
8.
Body, Jean‐Jacques, João Pereira, H.P. Sleeboom, et al.. (2015). Health resource utilization associated with skeletal-related events: results from a retrospective European study. The European Journal of Health Economics. 17(6). 711–721. 18 indexed citations
9.
Graham, Christopher N., Guy Hechmati, Marwan Fakih, et al.. (2015). Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-typeRASmetastatic colorectal cancer. Journal of Medical Economics. 18(8). 619–628. 7 indexed citations
10.
Peeters, Marc, George Kafatos, Aliki Taylor, et al.. (2015). Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials. European Journal of Cancer. 51(13). 1704–1713. 117 indexed citations
11.
Lüftner, Diana, Vito Lorusso, Ignacio Durán, et al.. (2014). Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study. SpringerPlus. 3(1). 328–328. 16 indexed citations
12.
13.
Body, Jean‐Jacques, Pierre Chevalier, Oliver Günther, Guy Hechmati, & Mark Lamotte. (2013). The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium. Journal of Medical Economics. 16(4). 539–546. 22 indexed citations
14.
Moróte, Juan, J.M. Cózar, Ignacio Durán, et al.. (2013). Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain. Value in Health. 16(7). A405–A405. 1 indexed citations
15.
Mohamed, Ateesha F., Yi Qian, Brett Hauber, et al.. (2013). Nurses’ Preferences for Bone Metastases Treatments in the United States. Value in Health. 16(7). A430–A430. 1 indexed citations
16.
Qian, Yi, Guy Hechmati, Ateesha F. Mohamed, et al.. (2013). Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom. Value in Health. 16(7). A430–A430. 2 indexed citations
17.
Hechmati, Guy, S. Cure, Vito Lorusso, et al.. (2013). Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study. Journal of Medical Economics. 16(5). 691–700. 46 indexed citations
18.
19.
Hechmati, Guy, Amit Bahl, Diana Lüftner, et al.. (2011). PCN76 SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES LEAD TO CONSIDERABLE HEALTH RESOURCE UTILISATION IN EUROPE: ANALYSIS OF A MULTINATIONAL OBSERVATIONAL STUDY. Value in Health. 14(3). A168–A168. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen S. Grubbs Breakdown of academic impact, for papers by Lucy McParland Breakdown of academic impact, for papers by Mario R. Velasco Breakdown of academic impact, for papers by Robert R. Carroll Breakdown of academic impact, for papers by Candice Johnstone Breakdown of academic impact, for papers by Dirk Elling Breakdown of academic impact, for papers by Karin Olson Breakdown of academic impact, for papers by Sophie Tartas Breakdown of academic impact, for papers by Amit Bahl Breakdown of academic impact, for papers by Şefik İğdem
Rankless by CCL
2026